Infectious Disease Diagnostics Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents, Kits and Consumables, Instruments, Software & Services), By Testing, Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Others), By Sample (Blood, Serum, Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
The global Infectious Disease Diagnostics market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Disease Diagnostics market across By Products and Services (Reagents, Kits and Consumables, Instruments, Software & Services), By Testing, Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Others), By Sample (Blood, Serum, Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others)
The infectious disease diagnostics market is characterized by the increasing demand for rapid and accurate detection of pathogens and infectious agents, advancements in molecular diagnostics and point-of-care testing, and the growing burden of emerging infectious diseases and pandemics. By 2030, the market is poised to witness steady growth, driven by innovations in nucleic acid amplification tests (NAATs), immunoassays, and biosensors. Further, expanding applications in respiratory infections, bloodstream infections, and sexually transmitted diseases are expected to drive market expansion, enabling clinical laboratories, hospitals, and urgent care centers to diagnose infectious diseases, monitor antimicrobial resistance, and guide treatment decisions through infectious disease diagnostics that offer sensitivity, specificity, and turnaround time for infectious disease management and public health response in the diagnostics market and clinical microbiology field.
Infectious Disease Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Diagnostics industry.
Key market trends defining the global Infectious Disease Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Infectious Disease Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Diagnostics industry
Leading Infectious Disease Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Diagnostics companies.
Infectious Disease Diagnostics Market Study- Strategic Analysis Review
The Infectious Disease Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Infectious Disease Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Infectious Disease Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Infectious Disease Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Infectious Disease Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Infectious Disease Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Infectious Disease Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Infectious Disease Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Diagnostics.
Infectious Disease Diagnostics Market Company Profiles
The global Infectious Disease Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Becton, Dickinson and Company, bioMйrieux SA, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, QIAGEN N.V., Revvity Inc, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Recent Infectious Disease Diagnostics Market Developments
The global Infectious Disease Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Reagents, Kits and Consumables
Instruments
Software & Services
By Testing
Laboratory Testing
PoC Testing
By Technology
Immunodiagnostics
Polymerase Chain Reaction
Clinical Microbiology
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Others
By Disease
Hepatitis
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Others
By Sample
Blood
Serum
Plasma
Urine
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Others
Geographical Segmentation:
Abbott Laboratories
Becton, Dickinson and Company
bioMйrieux SA
Danaher Corp
F. Hoffmann-La Roche Ltd
Hologic Inc
QIAGEN N.V.
Revvity Inc
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The infectious disease diagnostics market is characterized by the increasing demand for rapid and accurate detection of pathogens and infectious agents, advancements in molecular diagnostics and point-of-care testing, and the growing burden of emerging infectious diseases and pandemics. By 2030, the market is poised to witness steady growth, driven by innovations in nucleic acid amplification tests (NAATs), immunoassays, and biosensors. Further, expanding applications in respiratory infections, bloodstream infections, and sexually transmitted diseases are expected to drive market expansion, enabling clinical laboratories, hospitals, and urgent care centers to diagnose infectious diseases, monitor antimicrobial resistance, and guide treatment decisions through infectious disease diagnostics that offer sensitivity, specificity, and turnaround time for infectious disease management and public health response in the diagnostics market and clinical microbiology field.
Infectious Disease Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Disease Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Disease Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Disease Diagnostics industry.
Key market trends defining the global Infectious Disease Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Disease Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Infectious Disease Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Disease Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Disease Diagnostics industry
Leading Infectious Disease Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Disease Diagnostics companies.
Infectious Disease Diagnostics Market Study- Strategic Analysis Review
The Infectious Disease Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Infectious Disease Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Disease Diagnostics Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Infectious Disease Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Infectious Disease Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Infectious Disease Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Infectious Disease Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Disease Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Disease Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Infectious Disease Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Disease Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Disease Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Infectious Disease Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Infectious Disease Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Disease Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Disease Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Disease Diagnostics.
Infectious Disease Diagnostics Market Company Profiles
The global Infectious Disease Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Becton, Dickinson and Company, bioMйrieux SA, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, QIAGEN N.V., Revvity Inc, Seegene Inc, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Recent Infectious Disease Diagnostics Market Developments
The global Infectious Disease Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Disease Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Reagents, Kits and Consumables
Instruments
Software & Services
By Testing
Laboratory Testing
PoC Testing
By Technology
Immunodiagnostics
Polymerase Chain Reaction
Clinical Microbiology
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Others
By Disease
Hepatitis
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Others
By Sample
Blood
Serum
Plasma
Urine
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
Becton, Dickinson and Company
bioMйrieux SA
Danaher Corp
F. Hoffmann-La Roche Ltd
Hologic Inc
QIAGEN N.V.
Revvity Inc
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Infectious Disease Diagnostics Market Overview and Key Findings, 2024
1.2 Infectious Disease Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Diagnostics Market Growth Opportunities to 2030
1.4 Key Infectious Disease Diagnostics Market Trends and Challenges
1.4.1 Infectious Disease Diagnostics Market Drivers and Trends
1.4.2 Infectious Disease Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Diagnostics Companies
2. INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents, Kits and Consumables
Instruments
Software & Services
By Testing
Laboratory Testing
PoC Testing
By Technology
Immunodiagnostics
Polymerase Chain Reaction
Clinical Microbiology
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Others
By Disease
Hepatitis
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Others
By Sample
Blood
Serum
Plasma
Urine
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Diagnostics Market, 2025
5.2 Asia Pacific Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Diagnostics Market, 2025
5.5 Europe Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Diagnostics Market, 2025
5.8 North America Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Diagnostics Market, 2025
5.11 South America Pacific Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Diagnostics Market, 2025
5.14 Middle East Africa Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Diagnostics Industry Drivers and Opportunities
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Becton, Dickinson and Company
bioMйrieux SA
Danaher Corp
F. Hoffmann-La Roche Ltd
Hologic Inc
QIAGEN N.V.
Revvity Inc
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Infectious Disease Diagnostics Market Overview and Key Findings, 2024
1.2 Infectious Disease Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Disease Diagnostics Market Growth Opportunities to 2030
1.4 Key Infectious Disease Diagnostics Market Trends and Challenges
1.4.1 Infectious Disease Diagnostics Market Drivers and Trends
1.4.2 Infectious Disease Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Disease Diagnostics Companies
2. INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Disease Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Disease Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS DISEASE DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents, Kits and Consumables
Instruments
Software & Services
By Testing
Laboratory Testing
PoC Testing
By Technology
Immunodiagnostics
Polymerase Chain Reaction
Clinical Microbiology
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Others
By Disease
Hepatitis
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Others
By Sample
Blood
Serum
Plasma
Urine
Others
By End-User
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Disease Diagnostics Market, 2025
5.2 Asia Pacific Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Disease Diagnostics Market, 2025
5.5 Europe Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Disease Diagnostics Market, 2025
5.8 North America Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Disease Diagnostics Market, 2025
5.11 South America Pacific Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Disease Diagnostics Market, 2025
5.14 Middle East Africa Infectious Disease Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Disease Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Disease Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Disease Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Disease Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Disease Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Disease Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Disease Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Disease Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Disease Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Disease Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Disease Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Disease Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Disease Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Disease Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Disease Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Disease Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Disease Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Disease Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Disease Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Disease Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Disease Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Disease Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Disease Diagnostics Industry Drivers and Opportunities
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS DISEASE DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Infectious Disease Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Becton, Dickinson and Company
bioMйrieux SA
Danaher Corp
F. Hoffmann-La Roche Ltd
Hologic Inc
QIAGEN N.V.
Revvity Inc
Seegene Inc
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
